These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 35491282

  • 1. Investigation of the diversity of human papillomavirus 16 variants and L1 antigenic regions relevant for the prevention of human papillomavirus-related oropharyngeal cancer in Japan.
    Yoshida T, Ogawa T, Nakanome A, Ohkoshi A, Ishii R, Higashi K, Ishikawa T, Katori Y, Furukawa T.
    Auris Nasus Larynx; 2022 Dec; 49(6):1033-1041. PubMed ID: 35491282
    [Abstract] [Full Text] [Related]

  • 2. Prevalence and distribution of human papillomavirus (HPV) in Luoyang city of Henan province during 2015-2021 and the genetic variability of HPV16 and 52.
    Wang X, Han S, Li X, Wang X, Wang S, Ma L.
    Virol J; 2022 Mar 04; 19(1):37. PubMed ID: 35246180
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Genetic variation within the human papillomavirus type 16 genome is associated with oropharyngeal cancer prognosis.
    Lang Kuhs KA, Faden DL, Chen L, Smith DK, Pinheiro M, Wood CB, Davis S, Yeager M, Boland JF, Cullen M, Steinberg M, Bass S, Wang X, Liu P, Mehrad M, Tucker T, Lewis JS, Ferris RL, Mirabello L.
    Ann Oncol; 2022 Jun 04; 33(6):638-648. PubMed ID: 35306154
    [Abstract] [Full Text] [Related]

  • 5. HPV16 L1 diversity and its potential impact on the vaccination-induced immunity.
    El Aliani A, El Abid H, Kassal Y, Khyatti M, Attaleb M, Ennaji MM, El Mzibri M.
    Gene; 2020 Jul 15; 747():144682. PubMed ID: 32304786
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comprehensive Assessment of the Antigenic Impact of Human Papillomavirus Lineage Variation on Recognition by Neutralizing Monoclonal Antibodies Raised against Lineage A Major Capsid Proteins of Vaccine-Related Genotypes.
    Godi A, Boampong D, Elegunde B, Panwar K, Fleury M, Li S, Zhao Q, Xia N, Christensen ND, Beddows S.
    J Virol; 2020 Nov 23; 94(24):. PubMed ID: 32967963
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prognostic significance of human papillomavirus 16 viral load level in patients with oropharyngeal cancer.
    Hashida Y, Higuchi T, Matsumoto S, Iguchi M, Murakami I, Hyodo M, Daibata M.
    Cancer Sci; 2021 Oct 23; 112(10):4404-4417. PubMed ID: 34382311
    [Abstract] [Full Text] [Related]

  • 11. Genetic signatures for lineage/sublineage classification of HPV16, 18, 52 and 58 variants.
    Ou Z, Chen Z, Zhao Y, Lu H, Liu W, Li W, Ren P, Geng C, Xiao M, Hu G, Wu D, Wang X, Liu N, Zhu S, Lu L, Li J.
    Virology; 2021 Jan 15; 553():62-69. PubMed ID: 33238224
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Correlation between cervical HPV DNA detection and HPV16 seroreactivity measured with L1-only and L1+L2 viral capsid antigens.
    Trevisan A, Candeias JMG, Thomann P, Villa LL, Franco EL, Trottier H, The Ludwig-McGill Study Group.
    J Med Microbiol; 2020 Jul 15; 69(7):960-970. PubMed ID: 32510304
    [Abstract] [Full Text] [Related]

  • 16. High levels of HPV16-L1 antibody but not HPV16 DNA load or integration predict oropharyngeal patient outcome: The Papillophar study.
    Prétet JL, Dalstein V, Touzé A, Beby-Defaux A, Soussan P, Jacquin É, Birembaut P, Clavel C, Mougin C, Rousseau A, Lacau Saint Guily J, Papillophar Study Group.
    Clin Exp Med; 2023 Feb 15; 23(1):87-96. PubMed ID: 35199231
    [Abstract] [Full Text] [Related]

  • 17. Ancient Evolutionary History of Human Papillomavirus Type 16, 18 and 58 Variants Prevalent Exclusively in Japan.
    Tanaka K, Kogure G, Onuki M, Matsumoto K, Iwata T, Aoki D, Kukimoto I.
    Viruses; 2022 Feb 24; 14(3):. PubMed ID: 35336870
    [Abstract] [Full Text] [Related]

  • 18. Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study.
    Anantharaman D, Gheit T, Waterboer T, Abedi-Ardekani B, Carreira C, McKay-Chopin S, Gaborieau V, Marron M, Lagiou P, Ahrens W, Holcátová I, Merletti F, Kjaerheim K, Talamini R, Simonato L, Castellsague X, Macfarlane TV, Biggs AM, Thakker N, Znaor A, Thomson P, Canova C, Conway DI, Healy CM, Tommasino M, Pawlita M, Brennan P.
    J Natl Cancer Inst; 2013 Apr 17; 105(8):536-45. PubMed ID: 23503618
    [Abstract] [Full Text] [Related]

  • 19. Human Papillomavirus Vaccine to End Oropharyngeal Cancer. A Systematic Review and Meta-Analysis.
    Tsentemeidou A, Fyrmpas G, Stavrakas M, Vlachtsis K, Sotiriou E, Poutoglidis A, Tsetsos N.
    Sex Transm Dis; 2021 Sep 01; 48(9):700-707. PubMed ID: 34110733
    [Abstract] [Full Text] [Related]

  • 20. Factors Associated With Persistence and Clearance of High-Risk Oral Human Papillomavirus (HPV) Among Participants in the HPV Infection in Men (HIM) Study.
    Bettampadi D, Sirak BA, Abrahamsen ME, Reich RR, Villa LL, Ponce EL, Giuliano AR.
    Clin Infect Dis; 2021 Nov 02; 73(9):e3227-e3234. PubMed ID: 33173937
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.